Silence Therapeutics plc Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -24.59M-25.00M-41.80M-54.22M-59.31M-54.23M-45.31M
Depreciation and Depletion 0.51M0.58M0.61M0.57M0.40M0.40M0.34M
Share-based Compensation 0.91M0.75M5.64M11.88M12.69M16.27M16.31M
Deferred Taxes 0.69M0.96M0.84M
Gains from Sales and Divestitures 0.00M-0.00M
Gains from Investment Securities -0.01M-0.00M0.00M0.50M3.22M17.46M
Non-cash Items 2.34M3.01M29.10M
Cash from Operations -24.80M2.21M-17.71M9.36M-57.04M-49.46M-67.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.03M0.04M0.03M0.02M0.22M0.25M0.26M
Depreciation & Amortization (CF) 0.51M0.58M0.61M0.57M0.40M0.40M0.34M
Change in Working Capital
Change in Receivables 0.92M-0.01M-37.63M37.81M0.72M-0.39M0.90M
Change in Account Payables 1.53M3.90M1.67M3.31M1.79M0.05M
Change in Taxes 2.82M4.20M4.49M
Other Working Capital Changes -1.18M-0.01M-4.79M-1.24M-5.44M-10.32M0.46M
Investing Activities
Capital Expenditures 0.17M0.01M0.66M1.80M0.17M0.06M0.21M
Sales of Property, Plant and Equipment 0.00M
Change in Intangibles 0.37M
Cash from Investing Activities -6.45M-19.17M12.35M11.94M-20.50M19.29M-21.97M
Financing Activities
Cash from Financing Activities 0.46M6.73M19.81M42.25M52.58M31.94M142.09M
Additional items
Exchange Rate Effect -0.00M0.05M-0.43M-0.14M-8.12M0.75M0.06M
Change in Cash -28.38M-10.23M18.32M63.56M-24.96M1.77M52.48M
Free Cash Flow -24.98M2.19M-18.37M7.56M-57.22M-49.52M-67.85M
Net Cash Flow -30.80M-10.23M14.45M63.56M-24.96M1.77M52.48M